Power Law company profile

Neuren Pharmaceuticals

Biotech & Life Sciences · Melbourne, Australia · Founded 2001 · IPO 2005 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$828M

Market cap · Apr/2026

Revenue

$42M

Latest reported FY

See Neuren Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo